Format

Send to

Choose Destination
Leuk Lymphoma. 2019 Jan;60(1):262-264. doi: 10.1080/10428194.2018.1471602. Epub 2018 Jun 22.

PARP1 inhibitor eliminated imatinib-refractory chronic myeloid leukemia cells in bone marrow microenvironment conditions.

Author information

1
a Temple University Lewis Katz School of Medicine , Department of Microbiology and Immunology and Fels Institute for Cancer Research & Molecular Biology , Philadelphia , PA , USA.
2
b Laboratory of Cytometry , Nencki Institute of Experimental Biology , Warsaw , Poland.
PMID:
29932782
PMCID:
PMC6309580
[Available on 2020-01-01]
DOI:
10.1080/10428194.2018.1471602

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center